Novartis AG ADR [NVS] stock is trading at $108.06, down -0.06%. An important factor to consider is whether the stock is rising or falling in short-term value. The NVS shares have gain 1.50% over the last week, with a monthly amount glided 2.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on May 30, 2024, when Goldman initiated its Buy rating and assigned the stock a price target of $120. Previously, BMO Capital Markets started tracking the stock with Market Perform rating on February 23, 2024, and set its price target to $114. On January 23, 2024, Morgan Stanley initiated with a Equal-Weight rating and assigned a price target of $114 on the stock. HSBC Securities downgraded its rating to a Hold. Morgan Stanley upgraded its rating to Equal-Weight for this stock on September 25, 2023. In a note dated July 14, 2023, HSBC Securities initiated an Buy rating.
Novartis AG ADR [NVS] stock has fluctuated between $88.86 and $108.78 over the past year. Currently, Wall Street analysts expect the stock to reach $108 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $108.06 at the most recent close of the market. An investor can expect a potential drop of -0.06% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Novartis AG ADR [NYSE:NVS] reported sales of 48.66B for the trailing twelve months, which represents a drop of -8.68%. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.31%. To continue investigating profitability, this company’s Return on Assets is posted at 0.16, Equity is 0.35 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 107.69 points at the first support level, and at 107.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 108.61, and for the 2nd resistance point, it is at 109.16.
Ratios To Look Out For
For context, Novartis AG ADR’s Current Ratio is 0.90. On the other hand, the Quick Ratio is 0.71, and the Cash Ratio is 0.32. Considering the valuation of this stock, the price to sales ratio is 4.35, the price to book ratio is 5.56 and price to earnings (TTM) ratio is 14.67.
